CONGRATULATION ON FIRST PATIENT RANDOMIZED IN ASIA-PACIFIC (APAC) [MOR202C206]

Congratulations Associate Prof. Dr. Ng Kok Peng and the study team on the First Patient Randomized in Asia-Pacific (APAC) (Second Patient Randomized Globally) for the MOR202C206 study!!
Your hard work and effort are deeply meaningful to UMMC and the nation.

Details of the study: https://clinicaltrials.gov/ct2/show/NCT05065970

Anti-CD38Antibody, BeAHero, CICUMMC, ClinicalInvestigationCentre, ClinicalResearch,

ClinicalResearchinMalaysia, ClinicalTrials, Felzartamab, IgANephropathy, KidneyDisease,

LeaderinClinicalResearch, Malaysia, MOR202C206, Recruiting

 

Share:

More Posts

SELAMAT HARI RAYA AIDILFITRI 1445H

  Salam Aidilfitri dari CIC! Semoga Syawal ini diberkati dengan kegembiraan dan keberkatan untuk anda dan seluruh warga keluarga. #LeaderinClinicalResearch#ClinicalInvestigationcentre#ClinicalResearchinMalaysia#ClinicalResearch

Newsletter

Scroll to Top